Genprex Joins The Health Discovery Building At Dell Medical School To Help Drive Innovation For Health And Life Sciences

AUSTIN, Texas, April 18, 2018 /PRNewswire/  Genprex, Inc., a clinical stage gene therapy company developing immunogene therapy for non-small cell lung cancer, announced today that it has entered an agreement with The University of Texas at Austin Dell Medical School to establish executive offices at the school s Health Discovery Building, joining the WorkSpaces @ Texas Health CoLab that brings together value-focused health entrepreneurs and businesses to enable a robust health innovation ecosystem. Texas Health CoLab combines world-class research and technology capabilities, along with passionate The post Genprex Joins The Health Discovery Building At Dell Medical School To Help Drive Innovation For Health And Life Sciences appeared first on Public Wire.
http://bit.ly/2F0P4uu